The assembly of plasminogen and plasminogen activators on cell surfaces is a crucial control point for positive regulation of cell surface proteolytic activity necessary in both physiological and pathological processes requiring cell migration. The long-term goal of our laboratory is to understand the mechanisms by which plasminogen binding to cells is regulated, in order to function in physiological and pathological processes. This proposal is based on data demonstrating that up-regulation of plasminogen binding function occurs during differentiation of viable monocytes into viable macrophages. In preliminary studies, we identified three major candidate plasminogen receptors up-regulated in response to M-CSF that have not been recognized previously as plasminogen binding sites on monocytes. The objective of this application is to elucidate the role of M-CSF-up-regulated plasminogen receptors in monocyte/macrophage recruitment. The central hypothesis to be addressed is that plasminogen receptors are up-regulated during monocyte/macrophage maturation and facilitate recruitment of these cells in response to inflammatory stimuli, by promoting plasminogen activation and localizing the proteolytic activity of plasmin on the cell surface. To test this hypothesis we will I) identify the major pro- fibrinolytic plasminogen binding proteins on M-CSF-stimulated cells and quantify their expression during monocyte development in vivo and II) test the hypothesis that M-CSF-up-regulated plasminogen receptors promote plasminogen activation, extracellular matrix degradation and cell migration in vitro and in vivo. We expect that accomplishment of our specific aims will provide fundamental insights that will apply to the regulation of inflammation. Furthermore, because monocyte/macrophage recruitment and infiltration is a key feature of the atherosclerotic lesion, our results should apply to the understanding of atherosclerosis. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL081046-02
Application #
7393713
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Link, Rebecca P
Project Start
2007-04-06
Project End
2012-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
2
Fiscal Year
2008
Total Cost
$473,750
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Miles, L A; Baik, N; Bai, H et al. (2018) The plasminogen receptor, Plg-RKT, is essential for mammary lobuloalveolar development and lactation. J Thromb Haemost 16:919-932
Miles, Lindsey A; Parmer, Robert J (2017) tPA and anger management for macrophages. Blood 130:1280-1281
Sugimoto, Michelle A; Ribeiro, Ana Luíza C; Costa, Bruno R C et al. (2017) Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1. Blood 129:2896-2907
Miles, L A; Baik, N; Lighvani, S et al. (2017) Deficiency of plasminogen receptor, Plg-RKT , causes defects in plasminogen binding and inflammatory macrophage recruitment in vivo. J Thromb Haemost 15:155-162
Briens, Aurélien; Bardou, Isabelle; Lebas, Héloïse et al. (2017) Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin. Cell Discov 3:17001
Miles, Lindsey A; Parmer, Robert J (2016) Angry macrophages patrol for fibrin. Blood 127:1079-80
Miles, Lindsey A; Lighvani, Shahrzad; Baik, Nagyung et al. (2014) New insights into the role of Plg-RKT in macrophage recruitment. Int Rev Cell Mol Biol 309:259-302
Miles, Lindsey A; Parmer, Robert J (2014) Setting the table for macrophages. Blood 124:665-6
Gingles, N A; Bai, H; Miles, L A et al. (2013) Peptidergic regulation of plasminogen activator inhibitor-1 gene expression in vivo. J Thromb Haemost 11:1707-15
Miles, Lindsey A; Parmer, Robert J (2013) Plasminogen receptors: the first quarter century. Semin Thromb Hemost 39:329-37

Showing the most recent 10 out of 21 publications